Zubeen Shroff

Bio

Mr Shroff is a Managing Partner of Galen Partners, a leading healthcare growth equity investment firm founded in 1990. With over twenty years of experience in building life science companies, Mr. Shroff has acquired deep expertise, and demonstrated strong leadership in working with entrepreneurs to maximize shareholder value in the areas of: specialty pharmaceuticals, medical imaging, therapeutic devices, diagnostics, capital equipment, specialty supplies distribution, consumer driven healthcare, and technology enabled services. Prior to joining Galen in 1997, Mr. Shroff was a Principal at The Wilkerson Group, a leading medical products management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, plus a select number of venture capital firms. He played a major role in developing several of The Wilkerson Group’s practice areas, including outcomes research, strategy formulation, and disease management initiatives. Mr. Shroff started his career at Schering-Plough Pharmaceuticals where he directed the marketing, sales, and Phase IV clinical development activities for the company’s high growth biotech business in France. Mr Shroff serves on the Board of Directors for several public and private Galen portfolio companies. He is also a member of the Board of Directors for the Westchester Medical Center, as well as Chairman of its Foundation. He is a member of the Dean’s Advisory Committee for the Boston University Medical School. Mr. Shroff was a founding member of the Wharton Private Equity Network. He is a frequent speaker on: healthcare market trends, winning medical product and service business models, and the private equity investment climate. Mr Shroff earned an MBA from the Wharton School and a BA in biological science from Boston University.